These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 26314959

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
    Xu X, Chen R, Li Z, Huang N, Wu X, Li S, Li Y, Wu S.
    BMC Cancer; 2015 Dec 29; 15():1023. PubMed ID: 26714817
    [Abstract] [Full Text] [Related]

  • 3. MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10.
    Yang X, Chen J, Liao Y, Huang L, Wen C, Lin M, Li W, Zhu Y, Wu X, Iwamoto A, Wang Z, Liu H.
    Biosci Rep; 2019 Dec 20; 39(12):. PubMed ID: 31763673
    [Abstract] [Full Text] [Related]

  • 4. Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine.
    Liu M, Xu A, Yuan X, Zhang Q, Fang T, Wang W, Li C.
    J Transl Med; 2015 Jun 18; 13():195. PubMed ID: 26084278
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
    Gao Y, Liu Y, Du L, Li J, Qu A, Zhang X, Wang L, Wang C.
    Med Oncol; 2015 Jan 18; 32(1):362. PubMed ID: 25502080
    [Abstract] [Full Text] [Related]

  • 7. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
    Wang D, Feng M, Ma X, Tao K, Wang G.
    Life Sci; 2021 Jul 15; 277():119398. PubMed ID: 33831429
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
    Zhang L, Zhang Y, Zhu H, Sun X, Wang X, Wu P, Xu X.
    J Cell Biochem; 2019 Apr 15; 120(4):6078-6089. PubMed ID: 30362160
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17.
    Chen JT, Yao KH, Hua L, Zhang LP, Wang CY, Zhang JJ.
    Int J Clin Exp Pathol; 2015 Apr 15; 8(9):10922-8. PubMed ID: 26617808
    [Abstract] [Full Text] [Related]

  • 13. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
    Han Y, Kuang Y, Xue X, Guo X, Li P, Wang X, Guo X, Yuan B, Zhi Q, Zhao H.
    Biomed Pharmacother; 2014 Jun 15; 68(5):497-505. PubMed ID: 24972723
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro.
    Zhou W, Li X, Liu F, Xiao Z, He M, Shen S, Liu S.
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct 15; 44(10):838-46. PubMed ID: 23017832
    [Abstract] [Full Text] [Related]

  • 18. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
    Hu F, Min J, Cao X, Liu L, Ge Z, Hu J, Li X.
    Biochem Biophys Res Commun; 2016 May 20; 474(1):35-42. PubMed ID: 27084453
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of miR-518a-3p activates the NIK-dependent NF-κB pathway in colorectal cancer.
    Qu LL, He L, Zhao X, Xu W.
    Int J Mol Med; 2015 May 20; 35(5):1266-72. PubMed ID: 25812680
    [Abstract] [Full Text] [Related]

  • 20. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
    Zhao D, Sui Y, Zheng X.
    Oncol Rep; 2016 Feb 20; 35(2):1075-82. PubMed ID: 26718987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.